West Pharmaceutical Services Q2 FY26: where the revenue came from and where it went
The whole income statement of West Pharmaceutical Services for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2026
- Reported
- Jul 23, 2026
Revenue$0.87B
+14% year over year
Gross profit$0.33B
38% margin
Operating profit$0.18B
21% margin
Net profit$0.15B
18% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.87 | 100% | +14% |
| Proprietary products | 0.72 | 83% | +17% |
| West vantage | 0.15 | 17% | +2% |
| Cost of revenue | −0.54 | 62% | |
| Gross profit | 0.33 | 38% margin | +2pp |
| R&D | −0.02 | 2% | +0pp |
| SG&A | −0.12 | 13% | +1pp |
| Other | −0.01 | 2% | +0pp |
| Operating profit | 0.18 | 21% margin | +0pp |
| Other income, net | 0.01 | ||
| Tax | −0.03 | ||
| Net profit | 0.15 | 18% margin | +0pp |
303 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest